Vaccinex, Inc.

Vaccinex, Inc. (Vaccinex) is a biotechnology company which is engaged in the discovery and development of human monoclonal antibodies for the treatment of various serious diseases. Vaccinex is utilizing its patented ACTIVMAb technology to develop therapeutic antibodies for in-house development and co-development with partners. The product pipeline of Vaccinex include: BVX20-oncology; VX15-multiple sclerosis; VX15-oncology; VX5-multiple sclerosis, other autoimmune diseases and inflammation; VX35-oncology and Azintrel-inflammation. The company is headquartered at Rochester in New York, the US.

Street: 
1895 Mt. Hope Avenue
City: 
Rochester
Postcode: 
14620
Federal State : 
United States
WebSite: 
www.vaccinex.com
Fax: 
1-585-2712766

Company Index Score

Current Index Score Historical Index Score
  • Vaccinex, Inc. currently scores 50 % in the index.
  • Vaccinex, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Vaccinex, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets